Green tea and lung cancer: A systematic review

Integrative Cancer Therapies

Volumn 12, Issue 1, 2013, Pages 7-24

  Fritz, Heidi ^a   Seely, Dugald ^a,b,c   Kennedy, Deborah A ^a,d   Fernandes, Rochelle ^a,d   Cooley, Kieran ^a,d   Fergusson, Dean ^b  

^a CANADIAN COLLEGE OF NATUROPATHIC MEDICINE   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c Ottawa Integrative Cancer Centre   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Camellia sinensis; cancer; catechins; chemoprevention; complementary and alternative medicine; epigallocatechin gallate; green tea; herb drug interactions; lung cancer; natural health products; systematic review

Indexed keywords

BORTEZOMIB; CAFFEINE; CATECHIN; CISPLATIN; CURCUMIN; CYTOCHROME P450 1A2; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; EFLORNITHINE; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; ERLOTINIB; GEMCITABINE; GREEN TEA EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUTEOLIN; MITOGEN ACTIVATED PROTEIN KINASE; POLYPHENOL DERIVATIVE; PROTEIN P53; SELENITE; SULINDAC; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

AGITATION; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ANXIETY; APOPTOSIS; BURN; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER PREVENTION; CANCER RADIOTHERAPY; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL (TOPIC); COLORECTAL CANCER; CONSTIPATION; DIARRHEA; DNA DAMAGE; DRUG ANTAGONISM; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; FATIGUE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERTENSION; INSOMNIA; LEUKOPLAKIA; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAXIMUM TOLERATED DOSE; MESOTHELIOMA; METASTASIS INHIBITION; NAUSEA; NONHUMAN; PAIN; POLYDIPSIA; POLYPECTOMY; POLYURIA; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RADIATION INJURY; RESTLESSNESS; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW; TEA; TREATMENT RESPONSE; TUMOR CELL; UTERINE CERVIX DYSPLASIA;

ANIMALS; ANTINEOPLASTIC AGENTS; BORONIC ACIDS; DNA DAMAGE; HERB-DRUG INTERACTIONS; HUMANS; LUNG NEOPLASMS; MAXIMUM TOLERATED DOSE; PHYTOTHERAPY; PLANT EXTRACTS; PYRAZINES; TEA;

EID: 84871653622     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735412442378     Document Type: Review

References (130)

1. American Cancer Society. Cancer reference information: what are the key statistics about lung cancer?www.cancer.org. Accessed March 6, 2012.
2. Ross PJ, Ashley S, Norton A, et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?. Br J Cancer. 2004 ; 90: 1905-1911
3. Molassiotis A, Panteli V, Patiraki E, et al. Complementary and alternative medicine use in lung cancer patients in eight European countries. Complement Ther Clin Pract. 2006 ; 12: 34-39
4. Micke O, Buntzel J, Kisters K, Schafer U, Micke P, Mucke R. Complementary and alternative medicine in lung cancer patients: a neglected phenomenon?. Front Radiat Ther Oncol. 2010 ; 42: 198-205
5. Dou QP. Molecular mechanisms of green tea polyphenols. Nutr Cancer. 2009 ; 61: 827-835
6. Shi ST, Wang ZY, Smith TJ, et al. Effects of green tea and black tea on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation, DNA methylation, and lung tumorigenesis in A/J mice. Cancer Res. 1994 ; 54: 4641-4647
7. Zhang H, Spitz MR, Tomlinson GE, Schabath MB, Minna JD, Wu X. Modification of lung cancer susceptibility by green tea extract as measured by the comet assay. Cancer Detect Prev. 2002 ; 26: 411-418
8. Liao J, Yang GY, Park ES, et al. Inhibition of lung carcinogenesis and effects on angiogenesis and apoptosis in A/J mice by oral administration of green tea. Nutr Cancer. 2004 ; 48: 44-53
9. Tang N, Wu Y, Zhou B, Wang B, Yu R. Green tea, black tea consumption and risk of lung cancer: a meta-analysis. Lung Cancer. 2009 ; 65: 274-283
10. Clark J, You M. Chemoprevention of lung cancer by tea. Mol Nutr Food Res. 2006 ; 50: 144-151
11. Liang W, Binns CW, Jian L, Lee AH. Does the consumption of green tea reduce the risk of lung cancer among smokers?. Evid Based Complement Alternat Med. 2007 ; 4: 17-22
12. Schwartz JL, Baker V, Larios E, Chung FL. Molecular and cellular effects of green tea on oral cells of smokers: a pilot study. Mol Nutr Food Res. 2005 ; 49: 43-51
13. Imai K, Suga K, Nakachi K. Cancer-preventive effects of drinking green tea among a Japanese population. Prev Med. 1997 ; 26: 769-775
14. Khokhar S, Magnusdottir SG. Total phenol, catechin, and caffeine contents of teas commonly consumed in the United kingdom. J Agric Food Chem. 2002 ; 50: 565-570
15. Laurie SA, Miller VA, Grant SC, Kris MG, Ng KK. Phase I study of green tea extract in patients with advanced lung cancer. Cancer Chemother Pharmacol. 2005 ; 55: 33-38
16. Pisters KM, Newman RA, Coldman B, et al. Phase I trial of oral green tea extract in adult patients with solid tumors. J Clin Oncol. 2001 ; 19: 1830-1838
17. Lu G, Liao J, Yang G, Reuhl KR, Hao X, Yang CS. Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine. Cancer Res. 2006 ; 66: 11494-11501
18. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001 ; 134: 663-694
19. Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C. Recommendations for reporting randomized controlled trials of herbal interventions: explanation and elaboration. J Clin Epidemiol. 2006 ; 59: 1134-1149
20. Becker-Witt C, Weisshuhn TE, Ludtke R, Willich SN. Quality assessment of physical research in homeopathy. J Altern Complement Med. 2003 ; 9: 113-132
21. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996 ; 17: 1-12
22. Badari Nath AV, Madhusudhana Chetty C. In-vivo chemopreventive study of designed herbomineral tablet in tobacco smoke induced lung cancer animal model. Int J PharmTech Res. 2011 ; 3 (1). 13-17
23. Amin AR, Wang D, Zhang H, et al. Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin: potential role of p53. J Biol Chem. 2010 ; 285: 34557-34565
24. Li GX, Chen YK, Hou Z, et al. Pro-oxidative activities and dose-response relationship of (-)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro. Carcinogenesis. 2010 ; 31: 902-910
25. Roy P, Nigam N, Singh M, et al. Tea polyphenols inhibit cyclooxygenase-2 expression and block activation of nuclear factor-kappa B and Akt in diethylnitrosoamine induced lung tumors in Swiss mice. Invest New Drugs. 2010 ; 28: 466-471
26. Shimizu K, Kinouchi Shimizu N, Hakamata W, Unno K, Asai T, Oku N. Preventive effect of green tea catechins on experimental tumor metastasis in senescence-accelerated mice. Biol Pharm Bull. 2010 ; 33: 117-121
27. Zhang Q, Fu H, Pan J, et al. Effect of dietary polyphenon E and EGCG on lung tumorigenesis in A/J Mice. Pharm Res. 2010 ; 27: 1066-1071
28. Chan KH, Ho SP, Yeung SC, et al. Chinese green tea ameliorates lung injury in cigarette smoke-exposed rats. Respir Med. 2009 ; 103: 1746-1754
29. Gu Q, Hu C, Chen Q, Xia Y, Feng J, Yang H. Development of a rat model by 3,4-benzopyrene intra-pulmonary injection and evaluation of the effect of green tea drinking on p53 and bcl-2 expression in lung carcinoma. Cancer Detect Prev. 2009 ; 32: 444-451
30. Manna S, Mukherjee S, Roy A, Das S, Panda CK. Tea polyphenols can restrict benzo[a]pyrene-induced lung carcinogenesis by altered expression of p53-associated genes and H-ras, c-myc and cyclin D1. J Nutr Biochem. 2009 ; 20: 337-349
31. Milligan SA, Burke P, Coleman DT, et al. The green tea polyphenol EGCG potentiates the antiproliferative activity of c-Met and epidermal growth factor receptor inhibitors in non-small cell lung cancer cells. Clin Cancer Res. 2009 ; 15: 4885-4894
32. Roomi MW, Roomi NW, Kalinovsky T, Rath M, Niedzwiecki A. Chemopreventive effect of a novel nutrient mixture on lung tumorigenesis induced by urethane in male A/J mice. Tumori. 2009 ; 95: 508-513
33. Anderson MW, Goodin C, Zhang Y, et al. Effect of dietary green tea extract and aerosolized difluoromethylornithine during lung tumor progression in A/J strain mice. Carcinogenesis. 2008 ; 29: 1594-1600
34. Lu G, Xiao H, You H, et al. Synergistic inhibition of lung tumorigenesis by a combination of green tea polyphenols and atorvastatin. Clin Cancer Res. 2008 ; 14: 4981-4988
35. Lu Y, Yao R, Yan Y, et al. A gene expression signature that can predict green tea exposure and chemopreventive efficacy of lung cancer in mice. Cancer Res. 2006 ; 66: 1956-1963
36. Roomi MW, Roomi N, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M. Inhibition of pulmonary metastasis of melanoma b16fo cells in C57BL/6 mice by a nutrient mixture consisting of ascorbic acid, lysine, proline, arginine, and green tea extract. Exp Lung Res. 2006 ; 32: 517-530
37. Manna S, Banerjee S, Saha P, Roy A, Das S, Panda CK. Differential alterations in metabolic pattern of the spliceosomal UsnRNAs during pre-malignant lung lesions induced by benzo(a)pyrene: modulation by tea polyphenols. Mol Cell Biochem. 2006 ; 289: 149-157
38. Waheed Roomi M, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M. In vivo and in vitro antitumor effect of a unique nutrient mixture on lung cancer cell line A-549. Exp Lung Res. 2006 ; 32: 441-453
39. Yan Y, Wang Y, Tan Q, et al. Efficacy of polyphenon E, red ginseng, and rapamycin on benzo(a)pyrene-induced lung tumorigenesis in A/J mice. Neoplasia. 2006 ; 8: 52-58
40. Banerjee S, Manna S, Saha P, Panda CK, Das S. Black tea polyphenols suppress cell proliferation and induce apoptosis during benzo(a)pyrene-induced lung carcinogenesis. Eur J Cancer Prev. 2005 ; 14: 215-221
41. Saha P, Banerjee S, Ganguly C, Manna S, Panda CK, Das S. Black tea extract can modulate protein expression of H-ras, c-Myc, p53, and Bcl-2 genes during pulmonary hyperplasia, dysplasia, and carcinoma in situ. J Environ Pathol Toxicol Oncol. 2005 ; 24: 211-224
42. Schuller HM, Porter B, Riechert A, Walker K, Schmoyer R. Neuroendocrine lung carcinogenesis in hamsters is inhibited by green tea or theophylline while the development of adenocarcinomas is promoted: implications for chemoprevention in smokers. Lung Cancer. 2004 ; 45: 11-18
43. Hirose M, Hoshiya T, Mizoguchi Y, Nakamura A, Akagi K, Shirai T. Green tea catechins enhance tumor development in the colon without effects in the lung or thyroid after pretreatment with 1,2-dimethylhydrazine or 2,2'-dihydroxy-di-n-propylnitrosamine in male F344 rats. Cancer Lett. 2001 ; 168: 23-29
44. Liu JD, Chen SH, Lin CL, Tsai SH, Liang YC. Inhibition of melanoma growth and metastasis by combination with (-)-epigallocatechin-3-gallate and dacarbazine in mice. J Cell Biochem. 2001 ; 83: 631-642
45. Zhang Z, Liu Q, Lantry LE, et al. A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin. Cancer Res. 2000 ; 60: 901-907
46. Mimoto J, Kiura K, Matsuo K, et al. (-)-Epigallocatechin gallate can prevent cisplatin-induced lung tumorigenesis in A/J mice. Carcinogenesis. 2000 ; 21: 915-919
47. Gunning WT, Kramer PM, Lubet RA, Steele VE, Pereira MA. Chemoprevention of vinyl carbamate-induced lung tumors in strain A mice. Exp Lung Res. 2000 ; 26: 757-772
48. Witschi H. Successful and not so successful chemoprevention of tobacco smoke-induced lung tumors. Exp Lung Res. 2000 ; 26: 743-755
49. Schut HA, Yao R. Tea as a potential chemopreventive agent in PhIP carcinogenesis: effects of green tea and black tea on PhIP-DNA adduct formation in female F-344 rats. Nutr Cancer. 2000 ; 36: 52-58
50. Menon LG, Kuttan R, Kuttan G. Anti-metastatic activity of curcumin and catechin. Cancer Lett. 1999 ; 141: 159-165
51. Landau JM, Wang ZY, Yang GY, Ding W, Yang CS. Inhibition of spontaneous formation of lung tumors and rhabdomyosarcomas in A/J mice by black and green tea. Carcinogenesis. 1998 ; 19: 501-507
52. Witschi H, Espiritu I, Yu M, Willits NH. The effects of phenethyl isothiocyanate, N-acetylcysteine and green tea on tobacco smoke-induced lung tumors in strain A/J mice. Carcinogenesis. 1998 ; 19: 1789-1794
53. Cao J, Xu Y, Chen J, Klaunig JE. Chemopreventive effects of green and black tea on pulmonary and hepatic carcinogenesis. Fundam Appl Toxicol. 1996 ; 29: 244-250
54. Luo SQ, Liu XZ, Wang CJ. Inhibitory effect of green tea extract on the carcinogenesis induced by asbestos plus benzo(a)pyrene in rat. Biomed Environ Sci. 1995 ; 8: 54-58
55. Menon LG, Kuttan R, Kuttan G. Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett. 1995 ; 95: 221-225
56. Sazuka M, Murakami S, Isemura M, Satoh K, Nukiwa T. Inhibitory effects of green tea infusion on in vitro invasion and in vivo metastasis of mouse lung carcinoma cells. Cancer Lett. 1995 ; 98: 27-31
57. Katiyar SK, Agarwal R, Mukhtar H. Protective effects of green tea polyphenols administered by oral intubation against chemical carcinogen-induced forestomach and pulmonary neoplasia in A/J mice. Cancer Lett. 1993 ; 73: 167-172
58. Wang ZY, Agarwal R, Khan WA, Mukhtar H. Protection against benzo[a]pyrene- and N-nitrosodiethylamine-induced lung and forestomach tumorigenesis in A/J mice by water extracts of green tea and licorice. Carcinogenesis. 1992 ; 13: 1491-1494
59. Wang ZY, Hong JY, Huang MT, Reuhl KR, Conney AH, Yang CS. Inhibition of N-nitrosodiethylamine- and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone- induced tumorigenesis in A/J mice by green tea and black tea. Cancer Res. 1992 ; 52: 1943-1947
60. Xu Y, Ho CT, Amin SG, Han C, Chung FL. Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. Cancer Res. 1992 ; 52: 3875-3879
61. Taniguchi S, Fujiki H, Kobayashi H, et al. Effect of (-)- epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines. Cancer Lett. 1992 ; 65: 51-54
62. Conney AH, Wang ZY, Huang MT, Ho CT, Yang CS. Inhibitory effect of green tea on tumorigenesis by chemicals and ultraviolet light. Prev Med. 1992 ; 21: 361-369
63. Khan SG, Katiyar SK, Agarwal R, Mukhtar H. Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention. Cancer Res. 1992 ; 52: 4050-4052
64. Li W, Wu JX, Tu YY. Synergistic effects of tea polyphenols and ascorbic acid on human lung adenocarcinoma SPC-A-1 cells. J Zhejiang Univ Sci B. 2010 ; 11: 458-464
65. Saha A, Kuzuhara T, Echigo N, Suganuma M, Fujiki H. New role of (-)-epicatechin in enhancing the induction of growth inhibition and apoptosis in human lung cancer cells by curcumin. Cancer Prev Res (Phila). 2010 ; 3: 953-962
66. Shim JH, Su ZY, Chae JI, et al. Epigallocatechin gallate suppresses lung cancer cell growth through Ras-GTPase-activating protein SH3 domain-binding protein 1. Cancer Prev Res (Phila). 2010 ; 3: 670-679
67. Tan XL, Shi M, Tang H, Han W, Spivack SD. Candidate dietary phytochemicals modulate expression of phase II enzymes GSTP1 and NQO1 in human lung cells. J Nutr. 2010 ; 140: 1404-1410
68. Gao Z, Xu Z, Hung MS, et al. Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells. Anticancer Res. 2009 ; 29: 2025-2030
69. Lu QY, Yang Y, Jin YS, et al. Effects of green tea extract on lung cancer A549 cells: proteomic identification of proteins associated with cell migration. Proteomics. 2009 ; 9: 757-767
70. Tomankova K, Kolarova H, Bajgar R, Jirova D, Kejlova K, Mosinger J. Study of the photodynamic effect on the A549 cell line by atomic force microscopy and the influence of green tea extract on the production of reactive oxygen species. Ann N Y Acad Sci. 2009 ; 1171: 549-558
71. Yamauchi R, Sasaki K, Yoshida K. Identification of epigallocatechin-3- gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549. Toxicol In Vitro. 2009 ; 23: 834-839
72. Hazgui S, Bonnomet A, Nawrocki-Raby B, et al. Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells. Respir Res. 2008 ; 9: 33
73. Lambert JD, Sang S, Yang CS. N-Acetylcysteine enhances the lung cancer inhibitory effect of epigallocatechin-3- gallate and forms a new adduct. Free Radic Biol Med. 2008 ; 44: 1069-1074
74. Sadava D, Whitlock E, Kane SE. The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells. Biochem Biophys Res Commun. 2007 ; 360: 233-237
75. Kuzuhara T, Tanabe A, Sei Y, Yamaguchi K, Suganuma M, Fujiki H. Synergistic effects of multiple treatments, and both DNA and RNA direct bindings on, green tea catechins. Mol Carcinog. 2007 ; 46: 640-645
76. Lu QY, Jin YS, Zhang ZF, et al. Green tea induces annexin-I expression in human lung adenocarcinoma A549 cells: involvement of annexin-I in actin remodeling. Lab Invest. 2007 ; 87: 456-465
77. Suganuma M, Kurusu M, Suzuki K, Tasaki E, Fujiki H. Green tea polyphenol stimulates cancer preventive effects of celecoxib in human lung cancer cells by upregulation of GADD153 gene. Int J Cancer. 2006 ; 119: 33-40
78. Kweon MH, Adhami VM, Lee JS, Mukhtar H. Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. J Biol Chem. 2006 ; 281: 33761-33772
79. Ganguly C, Saha P, Panda CK, Das S. Inhibition of growth, induction of apoptosis and alteration of gene expression by tea polyphenols in the highly metastatic human lung cancer cell line NCI-H460. Asian Pac J Cancer Prev. 2005 ; 6: 326-331
80. Kuo PL, Hsu YL, Lin TC, Lin CC. The antiproliferative activity of prodelphinidin B-2 3'-O-gallate from green tea leaf is through cell cycle arrest and Fas-mediated apoptotic pathway in A549 cells. Food Chem Toxicol. 2005 ; 43: 315-323
81. Yang J, Wei D, Liu J. Repressions of MMP-9 expression and NF-kappa B localization are involved in inhibition of lung carcinoma 95-D cell invasion by (-)-epigallocatechin-3- gallate. Biomed Pharmacother. 2005 ; 59: 98-103
82. Shigeoka Y, Igishi T, Matsumoto S, et al. Sulindac sulfide and caffeic acid phenethyl ester suppress the motility of lung adenocarcinoma cells promoted by transforming growth factor-beta through Akt inhibition. J Cancer Res Clin Oncol. 2004 ; 130: 146-152
83. Vittal R, Selvanayagam ZE, Sun Y, et al. Gene expression changes induced by green tea polyphenol (-)-epigallocatechin-3-gallate in human bronchial epithelial 21BES cells analyzed by DNA microarray. Mol Cancer Ther. 2004 ; 3: 1091-1099
84. Tichelaar JW, Zhang Y, LeRiche JC, Lam S, Anderson MW. Activation of the Akt/nuclear factor-kappaB signaling axis in developing lung neoplasia. Chest. 2004 ; 125: 153S
85. Seeram NP, Zhang Y, Nair MG. Inhibition of proliferation of human cancer cells and cyclooxygenase enzymes by anthocyanidins and catechins. Nutr Cancer. 2003 ; 46: 101-106
86. Fujimoto N, Sueoka N, Sueoka E, et al. Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1. Int J Oncol. 2002 ; 20: 1233-1239
87. Okabe S, Fujimoto N, Sueoka N, Suganuma M, Fujiki H. Modulation of gene expression by (-)-epigallocatechin gallate in PC-9 cells using a cDNA expression array. Biol Pharm Bull. 2001 ; 24: 883-886
88. Steele VE, Kelloff GJ, Balentine D, et al. Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays. Carcinogenesis. 2000 ; 21: 63-67
89. Weitberg AB, Corvese D. The effect of epigallocatechin galleate and sarcophytol A on DNA strand breakage induced by tobacco-specific nitrosamines and stimulated human phagocytes. J Exp Clin Cancer Res. 1999 ; 18: 433-437
90. Suganuma M, Okabe S, Sueoka N, et al. Green tea and cancer chemoprevention. Mutat Res. 1999 ; 428: 339-344
91. Yang GY, Liao J, Kim K, Yurkow EJ, Yang CS. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis. 1998 ; 19: 611-616
92. Okabe S, Suganuma M, Hayashi M, Sueoka E, Komori A, Fujiki H. Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols. Jpn J Cancer Res. 1997 ; 88: 639-643
93. Leanderson P, Faresjo AO, Tagesson C. Green tea polyphenols inhibit oxidant-induced DNA strand breakage in cultured lung cells. Free Radic Biol Med. 1997 ; 23: 235-242
94. Sazuka M, Imazawa H, Shoji Y, Mita T, Hara Y, Isemura M. Inhibition of collagenases from mouse lung carcinoma cells by green tea catechins and black tea theaflavins. Biosci Biotechnol Biochem. 1997 ; 61: 1504-1506
95. Valcic S, Timmermann BN, Alberts DS, et al. Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anticancer Drugs. 1996 ; 7: 461-468
96. Ogata K, Mukae N, Suzuki Y, et al. Effects of catechins on the mouse tumor cell adhesion to fibronectin. Planta Med. 1995 ; 61: 472-474
97. Isemura M, Suzuki Y, Satoh K, Narumi K, Motomiya M. Effects of catechins on the mouse lung carcinoma cell adhesion to the endothelial cells. Cell Biol Int. 1993 ; 17: 559-564
98. Yu R, Jiao JJ, Duh JL, Gudehithlu K, Tan TH, Kong AN. Activation of mitogen-activated protein kinases by green tea polyphenols: potential signaling pathways in the regulation of antioxidant-responsive element-mediated phase II enzyme gene expression. Carcinogenesis. 1997 ; 18: 451-456
99. Chow HH, Hakim IA, Vining DR, et al. Effects of repeated green tea catechin administration on human cytochrome P450 activity. Cancer Epidemiol Biomarkers Prev. 2006 ; 15: 2473-2476
100. Donovan JL, Chavin KD, Devane CL, et al. Green tea (Camellia sinensis) extract does not alter cytochrome p450 3A4 or 2D6 activity in healthy volunteers. Drug Metab Dispos. 2004 ; 32: 906-908
101. Hakim IA, Chow HH, Harris RB. Green tea consumption is associated with decreased DNA damage among GSTM1-positive smokers regardless of their hOGG1 genotype. J Nutr. 2008 ; 138: 1567S - 1571S
102. Hakim IA, Harris RB, Brown S, et al. Effect of increased tea consumption on oxidative DNA damage among smokers: a randomized controlled study. J Nutr. 2003 ; 133: 3303S - 3309S
103. Hakim IA, Harris RB, Chow HH, Dean M, Brown S, Ali IU. Effect of a 4-month tea intervention on oxidative DNA damage among heavy smokers: role of glutathione S-transferase genotypes. Cancer Epidemiol Biomarkers Prev. 2004 ; 13: 242-249
104. Yano T, Shoji F, Baba H, et al. Significance of the urinary 8-OHdG level as an oxidative stress marker in lung cancer patients. Lung Cancer. 2009 ; 63: 111-114
105. Kanaya S, Ikeya M, Yamamoto K, et al. Comparison of an oxidative stress biomarker "urinary8-hydroxy-2'-deoxyguanosine," between smokers and non-smokers. Biofactors. 2004 ; 22: 255-258
106. Suga K, Imai K, Sueoka N, Nakachi K. Phase I clinical trial with green tea tablets in a Japanese healthy population. Cancer Prev Int. 1998 ; 10: 79-88
107. Golden EB, Lam PY, Kardosh A, et al. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood. 2009 ; 113: 5927-5937
108. Pajonk F, Riedisser A, Henke M, McBride WH, Fiebich B. The effects of tea extracts on proinflammatory signaling. BMC Med. 2006 ; 4: 28
109. Yuan JM. Green tea and prevention of esophageal and lung cancers. Mol Nutr Food Res. 2011 ; 55: 886-904
110. Shim JS, Kang MH, Kim YH, Roh JK, Roberts C, Lee IP. Chemopreventive effect of green tea (Camellia sinensis) among cigarette smokers. Cancer Epidemiol Biomarkers Prev. 1995 ; 4: 387-391
111. Cui Y, Morgenstern H, Greenland S, et al. Dietary flavonoid intake and lung cancer: a population-based case-control study. Cancer. 2008 ; 112: 2241-2248
112. Kubik A, Zatloukal P, Tomasek L, et al. A case-control study of lifestyle and lung cancer associations by histological types. Neoplasma. 2008 ; 55: 192-199
113. Zhong L, Goldberg MS, Gao YT, Hanley JA, Parent ME, Jin F. A population-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China. Epidemiology. 2001 ; 12: 695-700
114. Tsao AS, Liu D, Martin J, et al. Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev Res (Phila). 2009 ; 2: 931-941
115. Li N, Sun Z, Han C, Chen J. The chemopreventive effects of tea on human oral precancerous mucosa lesions. Proc Soc Exp Biol Med. 1999 ; 220: 218-224
116. Shimizu M, Fukutomi Y, Ninomiya M, et al. Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol Biomarkers Prev. 2008 ; 17: 3020-3025
117. Ahn WS, Yoo J, Huh SW, et al. Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. Eur J Cancer Prev. 2003 ; 12: 383-390
118. Brausi M, Rizzi F, Bettuzzi S. Chemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up update. Eur Urol. 2008 ; 54: 472-473
119. Shanafelt TD, Call TG, Zent CS, et al. Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia. J Clin Oncol. 2009 ; 27: 3808-3814
120. Ohno Y, Wakai K, Genka K, et al. Tea consumption and lung cancer risk: a case-control study in Okinawa, Japan. Jpn J Cancer Res. 1995 ; 86: 1027-1034
121. Boehm K, Borrelli F, Ernst E, et al. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev. 2009 ; (3). CD005004
122. Sinha D, Roy S, Roy M. Antioxidant potential of tea reduces arsenite induced oxidative stress in Swiss albino mice. Food Chem Toxicol. 2010 ; 48: 1032-1039
123. Kobayashi H, Tanaka Y, Asagiri K, et al. The antioxidant effect of green tea catechin ameliorates experimental liver injury. Phytomedicine. 2010 ; 17: 197-202
124. Kumar N, Kant R, Maurya PK. Concentration-dependent effect of (-) epicatechin in hypertensive patients. Phytother Res. 2010 ; 24: 1433-1436
125. Frei B, Higdon JV. Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr. 2003 ; 133: 3275S - 3284S
126. Benzie IF, Szeto YT, Strain JJ, Tomlinson B. Consumption of green tea causes rapid increase in plasma antioxidant power in humans. Nutr Cancer. 1999 ; 34: 83-87
127. Seely D, Mills EJ, Wu P, Verma S, Guyatt GH. The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: a systematic review and meta-analysis. Integr Cancer Ther. 2005 ; 4: 144-155
128. Mei Y, Qian F, Wei D, Liu J. Reversal of cancer multidrug resistance by green tea polyphenols. J Pharm Pharmacol. 2004 ; 56: 1307-1314
129. Jodoin J, Demeule M, Beliveau R. Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. Biochim Biophys Acta. 2002 ; 1542 (1-3). 149-159
130. Sadzuka Y, Sugiyama T, Sonobe T. Efficacies of tea components on doxorubicin induced antitumor activity and reversal of multidrug resistance. Toxicol Lett. 2000 ; 114: 155-162